Two year save outcomes: 2.0 mg Ranibizumab for Recalcitrant Neovascular AMD

Research output: Contribution to journal › Letter

ASJC Scopus subject areas

@article{dbd79df0a72c4041a663d54b2a03f3cf,

title = "Two year save outcomes: 2.0 mg Ranibizumab for Recalcitrant Neovascular AMD",

author = "Wykoff, {Charles C.} and Brown, {David M.} and Croft, {Daniel E.} and Wong, {Tien P.}",

year = "2013",

month = jan,

day = "1",

doi = "10.1016/j.ophtha.2013.06.030",

language = "English (US)",

volume = "120",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier",

number = "9",

}

TY - JOUR

T1 - Two year save outcomes

T2 - 2.0 mg Ranibizumab for Recalcitrant Neovascular AMD

AU - Wykoff, Charles C.

AU - Brown, David M.

AU - Croft, Daniel E.

AU - Wong, Tien P.

PY - 2013/1/1

Y1 - 2013/1/1

UR - http://www.scopus.com/inward/record.url?scp=84883801815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883801815&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2013.06.030

DO - 10.1016/j.ophtha.2013.06.030

M3 - Letter

C2 - 24001533

AN - SCOPUS:84883801815

VL - 120

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 9

ER -